Literature DB >> 9281509

Persistent echovirus infection of mouse cells expressing the viral receptor VLA-2.

S Zhang1, V R Racaniello.   

Abstract

Mouse cells are not susceptible to infection with echovirus 1 (EV-1) because they lack the viral receptor, human VLA-2. Two mouse fibroblast cell lines, L cells and 3T3 cells, were made susceptible to EV-1 infection after transformation with cDNAs of human VLA-2. After EV-1 infection, L cell transformants of human VLA-2 (alpha2beta1 L cells) develop cytopathic effect (CPE) as expected, while 3T3 cell transformants of human VLA-2 (alpha2beta1 3T3 cells) or the alpha2 subunit of human VLA-2 (alpha2 3T3 cells) become persistently infected. The distinct outcome is not a result of differential virus growth on these transformants because one-step growth curve analysis reveals little difference in EV-1 replication in both cell lines. In addition, 3T3 cell transformants expressing the poliovirus receptor (Pvr 3T3 cells) are lysed during poliovirus infection, suggesting that 3T3 cells are not intrinsically resistant to CPE caused by enterovirus infection. The results of limit dilution assays indicate that all EV-1-infected alpha2 3T3 cells produce infectious virus. All EV-1-infected alpha2 3T3 cells remain viable after EV-1 infection, and the kinetics of cell growth were not altered. FACS analysis reveals that receptor down-regulation is not involved in the establishment of persistent infection. Furthermore, inhibition of host protein synthesis was not observed in EV-1-infected alpha2 3T3 or alpha2beta1 L cells. Since alpha2beta1 L cells are lysed by EV-1 infection, these findings suggest that virus-induced translation inhibition is not a determinant of cell killing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9281509     DOI: 10.1006/viro.1997.8692

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer.

Authors:  Erin S Haley; Gough G Au; Brian R Carlton; Richard D Barry; Darren R Shafren
Journal:  J Mol Med (Berl)       Date:  2009-01-13       Impact factor: 4.599

2.  Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells.

Authors:  Julie R Harris; Vincent R Racaniello
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Transgenic mouse model for echovirus myocarditis and paralysis.

Authors:  Scott A Hughes; Harshwardhan M Thaker; Vincent R Racaniello
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

4.  Molecular mechanism of alpha2beta1 integrin interaction with human echovirus 1.

Authors:  Johanna Jokinen; Daniel J White; Maria Salmela; Mikko Huhtala; Jarmo Käpylä; Kalle Sipilä; J Santeri Puranen; Liisa Nissinen; Pasi Kankaanpää; Varpu Marjomäki; Timo Hyypiä; Mark S Johnson; Jyrki Heino
Journal:  EMBO J       Date:  2009-11-19       Impact factor: 11.598

5.  Subversion of cellular autophagosomal machinery by RNA viruses.

Authors:  William T Jackson; Thomas H Giddings; Matthew P Taylor; Sara Mulinyawe; Marlene Rabinovitch; Ron R Kopito; Karla Kirkegaard
Journal:  PLoS Biol       Date:  2005-04-26       Impact factor: 8.029

6.  Non-diarrhoeal increased frequency of bowel movements (IFoBM-ND): enterovirus association with the symptoms in children.

Authors:  C Durga Rao; P P Maiya; M Ananda Babu
Journal:  BMJ Open Gastroenterol       Date:  2015-02-06

7.  CpG and UpA dinucleotides in both coding and non-coding regions of echovirus 7 inhibit replication initiation post-entry.

Authors:  Jelke Jan Fros; Isabelle Dietrich; Kinda Alshaikhahmed; Tim Casper Passchier; David John Evans; Peter Simmonds
Journal:  Elife       Date:  2017-09-29       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.